These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Cell adhesion to collagen and decreased myogenic gene expression implicated in the control of myogenesis by transforming growth factor beta. Heino J, Massagué J. J Biol Chem; 1990 Jun 25; 265(18):10181-4. PubMed ID: 2162338 [Abstract] [Full Text] [Related]
8. Inhibition of myogenic differentiation by fibroblast growth factor or type beta transforming growth factor does not require persistent c-myc expression. Spizz G, Hu JS, Olson EN. Dev Biol; 1987 Oct 25; 123(2):500-7. PubMed ID: 3477514 [Abstract] [Full Text] [Related]
9. Transforming growth factor beta (TGF beta) causes a persistent increase in steady-state amounts of type I and type III collagen and fibronectin mRNAs in normal human dermal fibroblasts. Varga J, Rosenbloom J, Jimenez SA. Biochem J; 1987 Nov 01; 247(3):597-604. PubMed ID: 3501287 [Abstract] [Full Text] [Related]
10. Transforming growth factor beta induces myoblast differentiation in the presence of mitogens. Zentella A, Massagué J. Proc Natl Acad Sci U S A; 1992 Jun 01; 89(11):5176-80. PubMed ID: 1594628 [Abstract] [Full Text] [Related]
11. Decrease in transforming growth factor-beta binding and action during differentiation in muscle cells. Ewton DZ, Spizz G, Olson EN, Florini JR. J Biol Chem; 1988 Mar 15; 263(8):4029-32. PubMed ID: 2894374 [Abstract] [Full Text] [Related]
12. Interruption of myogenesis by transforming growth factor beta 1 or EGTA inhibits expression and activity of the myogenic-associated (2'-5') oligoadenylate synthetase and PKR. Salzberg S, Mandelboim M, Zalcberg M, Shainberg A. Exp Cell Res; 1995 Jul 15; 219(1):223-32. PubMed ID: 7628537 [Abstract] [Full Text] [Related]
13. Type-1 insulin-like growth factor receptor overexpression produces dual effects on myoblast proliferation and differentiation. Quinn LS, Steinmetz B, Maas A, Ong L, Kaleko M. J Cell Physiol; 1994 Jun 15; 159(3):387-98. PubMed ID: 8188756 [Abstract] [Full Text] [Related]
14. Inhibition of skeletal muscle satellite cell differentiation by transforming growth factor-beta. Allen RE, Boxhorn LK. J Cell Physiol; 1987 Dec 15; 133(3):567-72. PubMed ID: 3480289 [Abstract] [Full Text] [Related]
15. Type beta transforming growth factor controls the adipogenic differentiation of 3T3 fibroblasts. Ignotz RA, Massagué J. Proc Natl Acad Sci U S A; 1985 Dec 15; 82(24):8530-4. PubMed ID: 3001708 [Abstract] [Full Text] [Related]
16. Extracellular matrix proteoglycan decorin-mediated myogenic satellite cell responsiveness to transforming growth factor-beta1 during cell proliferation and differentiation Decorin and transforming growth factor-beta1 in satellite cells. Li X, McFarland DC, Velleman SG. Domest Anim Endocrinol; 2008 Oct 15; 35(3):263-73. PubMed ID: 18650056 [Abstract] [Full Text] [Related]
17. Regulation of fibronectin and type I collagen mRNA levels by transforming growth factor-beta. Ignotz RA, Endo T, Massagué J. J Biol Chem; 1987 May 15; 262(14):6443-6. PubMed ID: 3471760 [Abstract] [Full Text] [Related]
19. Transforming growth factor beta increases mRNA for matrix proteins both in the presence and in the absence of changes in mRNA stability. Penttinen RP, Kobayashi S, Bornstein P. Proc Natl Acad Sci U S A; 1988 Feb 15; 85(4):1105-8. PubMed ID: 3422482 [Abstract] [Full Text] [Related]
20. TGF-beta receptors, in a Smad-independent manner, are required for terminal skeletal muscle differentiation. Droguett R, Cabello-Verrugio C, Santander C, Brandan E. Exp Cell Res; 2010 Sep 10; 316(15):2487-503. PubMed ID: 20471380 [Abstract] [Full Text] [Related] Page: [Next] [New Search]